Related Experiment Video

Updated: May 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

[Anti RS virus drugs]

Hiroshi Suzumura1

  • 1Department of Pediatrics, Dokkyo Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 10, 2012
PubMed

Insights

Palivizumab effectively prevents respiratory syncytial virus (RSV) hospitalizations in high-risk infants. Newer monoclonal antibodies and vaccines are in development to further combat RSV infections.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Context:

  • Respiratory Syncytial Virus (RSV) poses a significant threat to vulnerable infant populations.
  • Current preventative measures include Palivizumab, a monoclonal antibody, for high-risk infants.
  • Existing treatments like Ribavirin have unclear efficacy.

Purpose:

  • To review the efficacy and limitations of Palivizumab for RSV prevention.
  • To discuss the development and potential of second-generation monoclonal antibodies like Motavizumab.
  • To highlight ongoing research into novel anti-RSV drugs and vaccines.

Summary:

  • Palivizumab reduces hospital admissions and length of stay for RSV-related lower respiratory tract infections in preterm infants, those with bronchopulmonary dysplasia, and congenital heart disease.
  • Motavizumab, a more potent second-generation antibody, showed promise but faced development hurdles due to skin complications.
  • Newer antiviral drugs and live attenuated intranasal vaccines targeting RSV are currently undergoing clinical trials.

Impact:

  • Palivizumab has established a standard of care for RSV prophylaxis in at-risk infants.
  • The development of Motavizumab underscores the potential for improved RSV therapeutics.
  • Ongoing research promises advanced strategies for RSV prevention and treatment, potentially reducing infant morbidity and mortality.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...